Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS
GENILCurrent price
150.00 TRY
+7.2 TRY (+5.04%)
Last closed
112.30 TRY
Company
www.genilac.com.tr
ISIN
TREGENL00024
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
Istanbul Stock Exchange
Capitalization
33 991 931 777 TRY
Yield for 12 month
+111.27 %
1Y
3Y
5Y
10Y
15Y
GENIL
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi, a pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide. The company offers its products in various areas, such as neurology, endocrinology, nephrology, oncology, hematology, and pediatric. Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi has collaboration with Sulfateq BV for the development of molecule SUL-238 as a treatment for Alzheimer's disease and other neurodegenerative diseases. The company was incorporated in 1997 and is headquartered in Çankaya, Turkey. Address: Mustafa Kemal District 2119, Çankaya, Turkey, 06520
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
4 331.95 TRYP/E ratio
45.26Dividend Yield
0.74 %Current Year
+8 195 483 698 TRY
Last Year
+5 474 524 658 TRY
Current Quarter
+3 171 946 102 TRY
Last Quarter
+3 116 067 488 TRY
Current Year
+1 809 134 733 TRY
Last Year
+1 147 161 075 TRY
Current Quarter
+598 598 588 TRY
Last Quarter
+634 388 382 TRY
Key Figures GENIL
1 year
3 years
5 years
10 years
EBITDA
1 542 757 123 TRY
Operating Margin TTM
PE Ratio
45.26
Return On Assets TTM
7.35 %
PEG Ratio
–
Return On Equity TTM
7.70 %
Wall Street Target Price
4 331.95 TRY
Revenue TTM
11 272 235 355 TRY
Book Value
21.45 TRY
Revenue Per Share TTM
Dividend Share
1.12 TRY
Quarterly Revenue Growth YOY
1.20 %
Dividend Yield
0.74 %
Gross Profit TTM
2 222 795 811 TRY
Earnings per share
2.50 TRY
Diluted Eps TTM
2.50 TRY
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
-65.80 %
Profit Margin
4.98 %
Dividend Analytics GENIL
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
21.00 %Dividend History GENIL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
08.10.2024
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
0
Consistent Years
2
Continuous Dividends
3
Forward Annual Dividend Yield
0.65 %
Forward Annual Dividend
0.74 TRY
Last Split Factor
–
Payout Ratio
3.62 %
Last Split Date
–
Stock Valuation GENIL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
45.26
Forward PE
–
Enterprise Value Revenue
3.20
Price Sales TTM
3.02
Enterprise Value EBITDA
23.77
Price Book MRQ
5.80
Financials GENIL
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators GENIL
For 52 weeks
53.66 TRY
125.37 TRY
50 Day MA
113.55 TRY
Shares Short Prior Month
–
200 Day MA
88.65 TRY
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart